ARTICLE | Company News
Genzyme, ViaCell deal
March 21, 2005 8:00 AM UTC
GENZ will use VIAC's adult islet stem cells in preclinical diabetes studies. GENZ also will study methods of improving production of the cells. Financial terms were not disclosed. ...